nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluticasone Propionate—PLA2G4A—breast cancer	0.157	0.534	CbGaD
Fluticasone Propionate—PGR—breast cancer	0.104	0.353	CbGaD
Fluticasone Propionate—PLA2G4A—Epirubicin—breast cancer	0.0511	0.194	CbGbCtD
Fluticasone Propionate—NR3C1—Fluoxymesterone—breast cancer	0.0498	0.189	CbGbCtD
Fluticasone Propionate—CYP3A4—breast cancer	0.0335	0.114	CbGaD
Fluticasone Propionate—Fluprednidene Acetate—Exemestane—breast cancer	0.0316	0.121	CrCrCtD
Fluticasone Propionate—Methylprednisolone—Exemestane—breast cancer	0.0295	0.113	CrCrCtD
Fluticasone Propionate—Amcinonide—Fluoxymesterone—breast cancer	0.0242	0.0925	CrCrCtD
Fluticasone Propionate—Clobetasol propionate—Fluoxymesterone—breast cancer	0.0236	0.0901	CrCrCtD
Fluticasone Propionate—Desoximetasone—Fluoxymesterone—breast cancer	0.0224	0.0857	CrCrCtD
Fluticasone Propionate—Fluprednidene Acetate—Fluoxymesterone—breast cancer	0.0219	0.0837	CrCrCtD
Fluticasone Propionate—Mometasone—Fluoxymesterone—breast cancer	0.0219	0.0837	CrCrCtD
Fluticasone Propionate—Triamcinolone—Fluoxymesterone—breast cancer	0.0219	0.0837	CrCrCtD
Fluticasone Propionate—Fluorometholone—Fluoxymesterone—breast cancer	0.0219	0.0837	CrCrCtD
Fluticasone Propionate—Dexamethasone—Fluoxymesterone—breast cancer	0.0214	0.0818	CrCrCtD
Fluticasone Propionate—Betamethasone—Fluoxymesterone—breast cancer	0.0214	0.0818	CrCrCtD
Fluticasone Propionate—CYP3A5—Lapatinib—breast cancer	0.013	0.0493	CbGbCtD
Fluticasone Propionate—CYP3A4—Exemestane—breast cancer	0.01	0.038	CbGbCtD
Fluticasone Propionate—CYP3A7-CYP3A51P—Tamoxifen—breast cancer	0.00868	0.0329	CbGbCtD
Fluticasone Propionate—CYP3A7—Tamoxifen—breast cancer	0.00868	0.0329	CbGbCtD
Fluticasone Propionate—CYP3A4—Letrozole—breast cancer	0.00852	0.0323	CbGbCtD
Fluticasone Propionate—CYP3A4—Anastrozole—breast cancer	0.0076	0.0288	CbGbCtD
Fluticasone Propionate—CYP3A4—Toremifene—breast cancer	0.00695	0.0264	CbGbCtD
Fluticasone Propionate—CYP3A7-CYP3A51P—Paclitaxel—breast cancer	0.00675	0.0256	CbGbCtD
Fluticasone Propionate—CYP3A7—Paclitaxel—breast cancer	0.00675	0.0256	CbGbCtD
Fluticasone Propionate—CYP3A7-CYP3A51P—Irinotecan—breast cancer	0.00666	0.0253	CbGbCtD
Fluticasone Propionate—CYP3A7—Irinotecan—breast cancer	0.00666	0.0253	CbGbCtD
Fluticasone Propionate—CYP3A5—Tamoxifen—breast cancer	0.00651	0.0247	CbGbCtD
Fluticasone Propionate—CYP3A4—Fulvestrant—breast cancer	0.00646	0.0245	CbGbCtD
Fluticasone Propionate—CYP3A4—Thiotepa—breast cancer	0.00576	0.0218	CbGbCtD
Fluticasone Propionate—CYP3A4—Ixabepilone—breast cancer	0.00526	0.02	CbGbCtD
Fluticasone Propionate—CYP3A4—Lapatinib—breast cancer	0.00507	0.0192	CbGbCtD
Fluticasone Propionate—CYP3A5—Paclitaxel—breast cancer	0.00507	0.0192	CbGbCtD
Fluticasone Propionate—PGR—corpus luteum—breast cancer	0.005	0.207	CbGeAlD
Fluticasone Propionate—CYP3A5—Irinotecan—breast cancer	0.005	0.019	CbGbCtD
Fluticasone Propionate—CYP3A7—Docetaxel—breast cancer	0.00488	0.0185	CbGbCtD
Fluticasone Propionate—CYP3A7-CYP3A51P—Docetaxel—breast cancer	0.00488	0.0185	CbGbCtD
Fluticasone Propionate—CYP3A4—Raloxifene—breast cancer	0.00384	0.0146	CbGbCtD
Fluticasone Propionate—CYP3A5—Docetaxel—breast cancer	0.00366	0.0139	CbGbCtD
Fluticasone Propionate—CYP3A4—Vinorelbine—breast cancer	0.00281	0.0107	CbGbCtD
Fluticasone Propionate—CYP3A4—Tamoxifen—breast cancer	0.00254	0.00963	CbGbCtD
Fluticasone Propionate—CYP3A4—Mitoxantrone—breast cancer	0.00247	0.00939	CbGbCtD
Fluticasone Propionate—CYP3A4—Paclitaxel—breast cancer	0.00198	0.0075	CbGbCtD
Fluticasone Propionate—CYP3A4—Irinotecan—breast cancer	0.00195	0.0074	CbGbCtD
Fluticasone Propionate—CYP3A4—Vinblastine—breast cancer	0.00173	0.00658	CbGbCtD
Fluticasone Propionate—CYP3A4—Docetaxel—breast cancer	0.00143	0.00542	CbGbCtD
Fluticasone Propionate—CYP3A4—Doxorubicin—breast cancer	0.00106	0.00404	CbGbCtD
Fluticasone Propionate—PLA2G4A—nipple—breast cancer	0.000848	0.0351	CbGeAlD
Fluticasone Propionate—PLA2G4A—Estradiol—Fulvestrant—breast cancer	0.000818	0.531	CbGdCrCtD
Fluticasone Propionate—PGR—mammary gland—breast cancer	0.000775	0.032	CbGeAlD
Fluticasone Propionate—NR3C2—nipple—breast cancer	0.00069	0.0285	CbGeAlD
Fluticasone Propionate—PGR—nipple—breast cancer	0.000641	0.0265	CbGeAlD
Fluticasone Propionate—PLA2G4A—endometrium—breast cancer	0.000512	0.0212	CbGeAlD
Fluticasone Propionate—PLA2G4A—Raltitrexed—Methotrexate—breast cancer	0.00049	0.318	CbGdCrCtD
Fluticasone Propionate—PLA2G4A—pituitary gland—breast cancer	0.000463	0.0192	CbGeAlD
Fluticasone Propionate—PLA2G4A—adipose tissue—breast cancer	0.000461	0.0191	CbGeAlD
Fluticasone Propionate—SERPINA6—pituitary gland—breast cancer	0.000461	0.0191	CbGeAlD
Fluticasone Propionate—CYP3A7—endocrine gland—breast cancer	0.000448	0.0185	CbGeAlD
Fluticasone Propionate—PGR—epithelium—breast cancer	0.000432	0.0178	CbGeAlD
Fluticasone Propionate—PLA2G4A—female reproductive system—breast cancer	0.000424	0.0175	CbGeAlD
Fluticasone Propionate—SERPINA6—female reproductive system—breast cancer	0.000422	0.0175	CbGeAlD
Fluticasone Propionate—NR3C2—endometrium—breast cancer	0.000416	0.0172	CbGeAlD
Fluticasone Propionate—PLA2G4A—adrenal gland—breast cancer	0.000414	0.0171	CbGeAlD
Fluticasone Propionate—SERPINA6—adrenal gland—breast cancer	0.000412	0.017	CbGeAlD
Fluticasone Propionate—PLA2G4A—bone marrow—breast cancer	0.0004	0.0166	CbGeAlD
Fluticasone Propionate—SERPINA6—bone marrow—breast cancer	0.000399	0.0165	CbGeAlD
Fluticasone Propionate—PGR—endometrium—breast cancer	0.000387	0.016	CbGeAlD
Fluticasone Propionate—PLA2G4A—female gonad—breast cancer	0.000386	0.016	CbGeAlD
Fluticasone Propionate—NR3C2—uterus—breast cancer	0.000384	0.0159	CbGeAlD
Fluticasone Propionate—NR3C2—pituitary gland—breast cancer	0.000377	0.0156	CbGeAlD
Fluticasone Propionate—NR3C2—adipose tissue—breast cancer	0.000375	0.0155	CbGeAlD
Fluticasone Propionate—NR3C1—nipple—breast cancer	0.00037	0.0153	CbGeAlD
Fluticasone Propionate—PLA2G4A—endocrine gland—breast cancer	0.000359	0.0148	CbGeAlD
Fluticasone Propionate—SERPINA6—endocrine gland—breast cancer	0.000357	0.0148	CbGeAlD
Fluticasone Propionate—PGR—uterus—breast cancer	0.000357	0.0147	CbGeAlD
Fluticasone Propionate—PGR—pituitary gland—breast cancer	0.00035	0.0145	CbGeAlD
Fluticasone Propionate—PGR—adipose tissue—breast cancer	0.000349	0.0144	CbGeAlD
Fluticasone Propionate—NR3C2—female reproductive system—breast cancer	0.000345	0.0143	CbGeAlD
Fluticasone Propionate—NR3C2—adrenal gland—breast cancer	0.000337	0.0139	CbGeAlD
Fluticasone Propionate—PGR—female reproductive system—breast cancer	0.000321	0.0133	CbGeAlD
Fluticasone Propionate—NR3C2—female gonad—breast cancer	0.000314	0.013	CbGeAlD
Fluticasone Propionate—PGR—adrenal gland—breast cancer	0.000313	0.0129	CbGeAlD
Fluticasone Propionate—NR3C1—embryo—breast cancer	0.000305	0.0126	CbGeAlD
Fluticasone Propionate—NR3C2—endocrine gland—breast cancer	0.000292	0.0121	CbGeAlD
Fluticasone Propionate—PGR—female gonad—breast cancer	0.000292	0.0121	CbGeAlD
Fluticasone Propionate—PGR—endocrine gland—breast cancer	0.000271	0.0112	CbGeAlD
Fluticasone Propionate—NR3C1—epithelium—breast cancer	0.000249	0.0103	CbGeAlD
Fluticasone Propionate—PLA2G4A—lymph node—breast cancer	0.000248	0.0103	CbGeAlD
Fluticasone Propionate—Fluocinolone Acetonide—PLA2G4A—breast cancer	0.000241	0.154	CrCbGaD
Fluticasone Propionate—NR3C1—skin of body—breast cancer	0.000237	0.0098	CbGeAlD
Fluticasone Propionate—NR3C1—endometrium—breast cancer	0.000223	0.00924	CbGeAlD
Fluticasone Propionate—NR3C1—uterus—breast cancer	0.000206	0.00851	CbGeAlD
Fluticasone Propionate—CYP3A5—adipose tissue—breast cancer	0.000203	0.00839	CbGeAlD
Fluticasone Propionate—NR3C1—pituitary gland—breast cancer	0.000202	0.00836	CbGeAlD
Fluticasone Propionate—NR3C2—lymph node—breast cancer	0.000202	0.00834	CbGeAlD
Fluticasone Propionate—NR3C1—adipose tissue—breast cancer	0.000201	0.00832	CbGeAlD
Fluticasone Propionate—PGR—lymph node—breast cancer	0.000188	0.00776	CbGeAlD
Fluticasone Propionate—NR3C1—female reproductive system—breast cancer	0.000185	0.00765	CbGeAlD
Fluticasone Propionate—NR3C1—adrenal gland—breast cancer	0.000181	0.00747	CbGeAlD
Fluticasone Propionate—NR3C1—bone marrow—breast cancer	0.000175	0.00722	CbGeAlD
Fluticasone Propionate—CYP3A5—female gonad—breast cancer	0.00017	0.00702	CbGeAlD
Fluticasone Propionate—NR3C1—female gonad—breast cancer	0.000168	0.00696	CbGeAlD
Fluticasone Propionate—CYP3A5—endocrine gland—breast cancer	0.000158	0.00652	CbGeAlD
Fluticasone Propionate—NR3C1—endocrine gland—breast cancer	0.000157	0.00647	CbGeAlD
Fluticasone Propionate—CYP3A4—female reproductive system—breast cancer	0.00014	0.00579	CbGeAlD
Fluticasone Propionate—CYP3A4—endocrine gland—breast cancer	0.000118	0.0049	CbGeAlD
Fluticasone Propionate—PLA2G4A—Dexamethasone—Fluoxymesterone—breast cancer	0.000117	0.0758	CbGdCrCtD
Fluticasone Propionate—PLA2G4A—Betamethasone—Fluoxymesterone—breast cancer	0.000117	0.0758	CbGdCrCtD
Fluticasone Propionate—NR3C1—lymph node—breast cancer	0.000108	0.00448	CbGeAlD
Fluticasone Propionate—Betamethasone—PGR—breast cancer	9.98e-05	0.0637	CrCbGaD
Fluticasone Propionate—Triamcinolone—BCHE—breast cancer	8.34e-05	0.0533	CrCbGaD
Fluticasone Propionate—Clobetasol propionate—CYP1A1—breast cancer	7.83e-05	0.05	CrCbGaD
Fluticasone Propionate—Dexamethasone—CYP17A1—breast cancer	7.83e-05	0.05	CrCbGaD
Fluticasone Propionate—Betamethasone—CYP19A1—breast cancer	6.85e-05	0.0437	CrCbGaD
Fluticasone Propionate—Dexamethasone—NOS2—breast cancer	6.38e-05	0.0408	CrCbGaD
Fluticasone Propionate—Fluticasone furoate—CYP3A4—breast cancer	5.84e-05	0.0373	CrCbGaD
Fluticasone Propionate—Dexamethasone—PGR—breast cancer	5.81e-05	0.0371	CrCbGaD
Fluticasone Propionate—Dexamethasone—CYP1B1—breast cancer	5.43e-05	0.0347	CrCbGaD
Fluticasone Propionate—Alclometasone—CYP3A4—breast cancer	5.13e-05	0.0328	CrCbGaD
Fluticasone Propionate—Flunisolide—CYP3A4—breast cancer	5e-05	0.0319	CrCbGaD
Fluticasone Propionate—Paramethasone—CYP3A4—breast cancer	4.93e-05	0.0315	CrCbGaD
Fluticasone Propionate—Fluticasone furoate—ABCB1—breast cancer	4.86e-05	0.0311	CrCbGaD
Fluticasone Propionate—Fluorometholone—CYP3A4—breast cancer	4.82e-05	0.0308	CrCbGaD
Fluticasone Propionate—Methylprednisolone—CYP3A4—breast cancer	4.66e-05	0.0297	CrCbGaD
Fluticasone Propionate—Dexamethasone—CYP19A1—breast cancer	3.98e-05	0.0254	CrCbGaD
Fluticasone Propionate—Triamcinolone—CYP3A4—breast cancer	3.93e-05	0.0251	CrCbGaD
Fluticasone Propionate—Methylprednisolone—ABCB1—breast cancer	3.88e-05	0.0248	CrCbGaD
Fluticasone Propionate—Triamcinolone—PTGS2—breast cancer	3.84e-05	0.0246	CrCbGaD
Fluticasone Propionate—Dexamethasone—ABCG2—breast cancer	3.74e-05	0.0239	CrCbGaD
Fluticasone Propionate—Betamethasone—CYP3A4—breast cancer	3.22e-05	0.0205	CrCbGaD
Fluticasone Propionate—Betamethasone—PTGS2—breast cancer	3.15e-05	0.0201	CrCbGaD
Fluticasone Propionate—Dexamethasone—CYP1A1—breast cancer	2.93e-05	0.0187	CrCbGaD
Fluticasone Propionate—Dermatitis—Thiotepa—breast cancer	2.78e-05	0.000296	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Paclitaxel—breast cancer	2.77e-05	0.000295	CcSEcCtD
Fluticasone Propionate—Headache—Thiotepa—breast cancer	2.76e-05	0.000294	CcSEcCtD
Fluticasone Propionate—Palpitations—Capecitabine—breast cancer	2.76e-05	0.000294	CcSEcCtD
Fluticasone Propionate—Arthralgia—Docetaxel—breast cancer	2.74e-05	0.000293	CcSEcCtD
Fluticasone Propionate—Chest pain—Docetaxel—breast cancer	2.74e-05	0.000293	CcSEcCtD
Fluticasone Propionate—Nausea—Vinorelbine—breast cancer	2.74e-05	0.000292	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	2.73e-05	0.000291	CcSEcCtD
Fluticasone Propionate—Cough—Capecitabine—breast cancer	2.72e-05	0.00029	CcSEcCtD
Fluticasone Propionate—Conjunctivitis—Epirubicin—breast cancer	2.7e-05	0.000288	CcSEcCtD
Fluticasone Propionate—Hypertension—Capecitabine—breast cancer	2.69e-05	0.000287	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Fluorouracil—breast cancer	2.69e-05	0.000286	CcSEcCtD
Fluticasone Propionate—Dry mouth—Docetaxel—breast cancer	2.68e-05	0.000286	CcSEcCtD
Fluticasone Propionate—Upper respiratory tract infection—Doxorubicin—breast cancer	2.68e-05	0.000286	CcSEcCtD
Fluticasone Propionate—Betamethasone—ABCB1—breast cancer	2.68e-05	0.0171	CrCbGaD
Fluticasone Propionate—Arthralgia—Capecitabine—breast cancer	2.66e-05	0.000283	CcSEcCtD
Fluticasone Propionate—Chest pain—Capecitabine—breast cancer	2.66e-05	0.000283	CcSEcCtD
Fluticasone Propionate—Pain—Paclitaxel—breast cancer	2.65e-05	0.000283	CcSEcCtD
Fluticasone Propionate—Pharyngitis—Methotrexate—breast cancer	2.65e-05	0.000282	CcSEcCtD
Fluticasone Propionate—Anxiety—Capecitabine—breast cancer	2.65e-05	0.000282	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	2.64e-05	0.000281	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Docetaxel—breast cancer	2.63e-05	0.000281	CcSEcCtD
Fluticasone Propionate—Oedema—Docetaxel—breast cancer	2.63e-05	0.000281	CcSEcCtD
Fluticasone Propionate—Discomfort—Capecitabine—breast cancer	2.62e-05	0.00028	CcSEcCtD
Fluticasone Propionate—Epistaxis—Epirubicin—breast cancer	2.62e-05	0.00028	CcSEcCtD
Fluticasone Propionate—Pruritus—Gemcitabine—breast cancer	2.62e-05	0.00028	CcSEcCtD
Fluticasone Propionate—Nausea—Thiotepa—breast cancer	2.62e-05	0.000279	CcSEcCtD
Fluticasone Propionate—Infection—Docetaxel—breast cancer	2.61e-05	0.000279	CcSEcCtD
Fluticasone Propionate—Sinusitis—Epirubicin—breast cancer	2.61e-05	0.000278	CcSEcCtD
Fluticasone Propionate—Hyperglycaemia—Doxorubicin—breast cancer	2.6e-05	0.000278	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Mitoxantrone—breast cancer	2.6e-05	0.000278	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Irinotecan—breast cancer	2.6e-05	0.000278	CcSEcCtD
Fluticasone Propionate—Dry mouth—Capecitabine—breast cancer	2.6e-05	0.000277	CcSEcCtD
Fluticasone Propionate—Pneumonia—Doxorubicin—breast cancer	2.59e-05	0.000276	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Docetaxel—breast cancer	2.58e-05	0.000275	CcSEcCtD
Fluticasone Propionate—Pruritus—Fluorouracil—breast cancer	2.58e-05	0.000275	CcSEcCtD
Fluticasone Propionate—Infestation—Doxorubicin—breast cancer	2.57e-05	0.000274	CcSEcCtD
Fluticasone Propionate—Infestation NOS—Doxorubicin—breast cancer	2.57e-05	0.000274	CcSEcCtD
Fluticasone Propionate—Tachycardia—Docetaxel—breast cancer	2.57e-05	0.000274	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Paclitaxel—breast cancer	2.56e-05	0.000273	CcSEcCtD
Fluticasone Propionate—Skin disorder—Docetaxel—breast cancer	2.55e-05	0.000272	CcSEcCtD
Fluticasone Propionate—Oedema—Capecitabine—breast cancer	2.55e-05	0.000272	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Paclitaxel—breast cancer	2.54e-05	0.000271	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Gemcitabine—breast cancer	2.54e-05	0.00027	CcSEcCtD
Fluticasone Propionate—Infection—Capecitabine—breast cancer	2.53e-05	0.00027	CcSEcCtD
Fluticasone Propionate—Dizziness—Irinotecan—breast cancer	2.52e-05	0.000268	CcSEcCtD
Fluticasone Propionate—Conjunctivitis—Doxorubicin—breast cancer	2.5e-05	0.000267	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Capecitabine—breast cancer	2.5e-05	0.000266	CcSEcCtD
Fluticasone Propionate—Eye disorder—Methotrexate—breast cancer	2.49e-05	0.000266	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Fluorouracil—breast cancer	2.49e-05	0.000266	CcSEcCtD
Fluticasone Propionate—Tachycardia—Capecitabine—breast cancer	2.49e-05	0.000265	CcSEcCtD
Fluticasone Propionate—Hypoaesthesia—Epirubicin—breast cancer	2.48e-05	0.000265	CcSEcCtD
Fluticasone Propionate—Pharyngitis—Epirubicin—breast cancer	2.48e-05	0.000264	CcSEcCtD
Fluticasone Propionate—Cardiac disorder—Methotrexate—breast cancer	2.48e-05	0.000264	CcSEcCtD
Fluticasone Propionate—Skin disorder—Capecitabine—breast cancer	2.47e-05	0.000264	CcSEcCtD
Fluticasone Propionate—Urticaria—Paclitaxel—breast cancer	2.47e-05	0.000263	CcSEcCtD
Fluticasone Propionate—Connective tissue disorder—Epirubicin—breast cancer	2.45e-05	0.000262	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Paclitaxel—breast cancer	2.45e-05	0.000262	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Paclitaxel—breast cancer	2.45e-05	0.000262	CcSEcCtD
Fluticasone Propionate—Epistaxis—Doxorubicin—breast cancer	2.43e-05	0.000259	CcSEcCtD
Fluticasone Propionate—Vomiting—Mitoxantrone—breast cancer	2.42e-05	0.000258	CcSEcCtD
Fluticasone Propionate—Vomiting—Irinotecan—breast cancer	2.42e-05	0.000258	CcSEcCtD
Fluticasone Propionate—Sinusitis—Doxorubicin—breast cancer	2.41e-05	0.000258	CcSEcCtD
Fluticasone Propionate—Immune system disorder—Methotrexate—breast cancer	2.41e-05	0.000257	CcSEcCtD
Fluticasone Propionate—Dizziness—Fluorouracil—breast cancer	2.41e-05	0.000257	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Methotrexate—breast cancer	2.4e-05	0.000256	CcSEcCtD
Fluticasone Propionate—Rash—Mitoxantrone—breast cancer	2.4e-05	0.000256	CcSEcCtD
Fluticasone Propionate—Rash—Irinotecan—breast cancer	2.4e-05	0.000256	CcSEcCtD
Fluticasone Propionate—Dermatitis—Mitoxantrone—breast cancer	2.4e-05	0.000256	CcSEcCtD
Fluticasone Propionate—Dermatitis—Irinotecan—breast cancer	2.4e-05	0.000256	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Docetaxel—breast cancer	2.4e-05	0.000256	CcSEcCtD
Fluticasone Propionate—Headache—Irinotecan—breast cancer	2.38e-05	0.000254	CcSEcCtD
Fluticasone Propionate—Headache—Mitoxantrone—breast cancer	2.38e-05	0.000254	CcSEcCtD
Fluticasone Propionate—Vomiting—Gemcitabine—breast cancer	2.36e-05	0.000251	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Docetaxel—breast cancer	2.35e-05	0.00025	CcSEcCtD
Fluticasone Propionate—Mental disorder—Methotrexate—breast cancer	2.34e-05	0.000249	CcSEcCtD
Fluticasone Propionate—Rash—Gemcitabine—breast cancer	2.34e-05	0.000249	CcSEcCtD
Fluticasone Propionate—Dermatitis—Gemcitabine—breast cancer	2.33e-05	0.000249	CcSEcCtD
Fluticasone Propionate—Eye disorder—Epirubicin—breast cancer	2.33e-05	0.000249	CcSEcCtD
Fluticasone Propionate—Malnutrition—Methotrexate—breast cancer	2.32e-05	0.000248	CcSEcCtD
Fluticasone Propionate—Erythema—Methotrexate—breast cancer	2.32e-05	0.000248	CcSEcCtD
Fluticasone Propionate—Headache—Gemcitabine—breast cancer	2.32e-05	0.000248	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Capecitabine—breast cancer	2.32e-05	0.000247	CcSEcCtD
Fluticasone Propionate—Cardiac disorder—Epirubicin—breast cancer	2.32e-05	0.000247	CcSEcCtD
Fluticasone Propionate—Vomiting—Fluorouracil—breast cancer	2.32e-05	0.000247	CcSEcCtD
Fluticasone Propionate—Hypoaesthesia—Doxorubicin—breast cancer	2.3e-05	0.000245	CcSEcCtD
Fluticasone Propionate—Rash—Fluorouracil—breast cancer	2.3e-05	0.000245	CcSEcCtD
Fluticasone Propionate—Dermatitis—Fluorouracil—breast cancer	2.3e-05	0.000245	CcSEcCtD
Fluticasone Propionate—Pharyngitis—Doxorubicin—breast cancer	2.29e-05	0.000245	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Paclitaxel—breast cancer	2.29e-05	0.000244	CcSEcCtD
Fluticasone Propionate—Headache—Fluorouracil—breast cancer	2.28e-05	0.000243	CcSEcCtD
Fluticasone Propionate—Connective tissue disorder—Doxorubicin—breast cancer	2.27e-05	0.000242	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Capecitabine—breast cancer	2.27e-05	0.000242	CcSEcCtD
Fluticasone Propionate—Nausea—Irinotecan—breast cancer	2.26e-05	0.000241	CcSEcCtD
Fluticasone Propionate—Nausea—Mitoxantrone—breast cancer	2.26e-05	0.000241	CcSEcCtD
Fluticasone Propionate—Immune system disorder—Epirubicin—breast cancer	2.26e-05	0.000241	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Epirubicin—breast cancer	2.25e-05	0.00024	CcSEcCtD
Fluticasone Propionate—Pain—Docetaxel—breast cancer	2.25e-05	0.00024	CcSEcCtD
Fluticasone Propionate—Arrhythmia—Epirubicin—breast cancer	2.23e-05	0.000238	CcSEcCtD
Fluticasone Propionate—Nausea—Gemcitabine—breast cancer	2.2e-05	0.000235	CcSEcCtD
Fluticasone Propionate—Pruritus—Paclitaxel—breast cancer	2.2e-05	0.000234	CcSEcCtD
Fluticasone Propionate—Vision blurred—Methotrexate—breast cancer	2.19e-05	0.000233	CcSEcCtD
Fluticasone Propionate—Mental disorder—Epirubicin—breast cancer	2.19e-05	0.000233	CcSEcCtD
Fluticasone Propionate—Dexamethasone—CYP2D6—breast cancer	2.18e-05	0.0139	CrCbGaD
Fluticasone Propionate—Pain—Capecitabine—breast cancer	2.18e-05	0.000232	CcSEcCtD
Fluticasone Propionate—Malnutrition—Epirubicin—breast cancer	2.17e-05	0.000232	CcSEcCtD
Fluticasone Propionate—Erythema—Epirubicin—breast cancer	2.17e-05	0.000232	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Docetaxel—breast cancer	2.17e-05	0.000231	CcSEcCtD
Fluticasone Propionate—Nausea—Fluorouracil—breast cancer	2.16e-05	0.000231	CcSEcCtD
Fluticasone Propionate—Eye disorder—Doxorubicin—breast cancer	2.16e-05	0.00023	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Methotrexate—breast cancer	2.16e-05	0.00023	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Docetaxel—breast cancer	2.15e-05	0.000229	CcSEcCtD
Fluticasone Propionate—Cardiac disorder—Doxorubicin—breast cancer	2.14e-05	0.000229	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Paclitaxel—breast cancer	2.12e-05	0.000226	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Capecitabine—breast cancer	2.1e-05	0.000224	CcSEcCtD
Fluticasone Propionate—Malaise—Methotrexate—breast cancer	2.09e-05	0.000223	CcSEcCtD
Fluticasone Propionate—Muscle spasms—Epirubicin—breast cancer	2.09e-05	0.000223	CcSEcCtD
Fluticasone Propionate—Immune system disorder—Doxorubicin—breast cancer	2.09e-05	0.000223	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Capecitabine—breast cancer	2.08e-05	0.000222	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Doxorubicin—breast cancer	2.08e-05	0.000222	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Docetaxel—breast cancer	2.08e-05	0.000222	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Docetaxel—breast cancer	2.08e-05	0.000222	CcSEcCtD
Fluticasone Propionate—Arrhythmia—Doxorubicin—breast cancer	2.06e-05	0.00022	CcSEcCtD
Fluticasone Propionate—Dizziness—Paclitaxel—breast cancer	2.05e-05	0.000219	CcSEcCtD
Fluticasone Propionate—Vision blurred—Epirubicin—breast cancer	2.05e-05	0.000218	CcSEcCtD
Fluticasone Propionate—Cough—Methotrexate—breast cancer	2.03e-05	0.000216	CcSEcCtD
Fluticasone Propionate—Mental disorder—Doxorubicin—breast cancer	2.02e-05	0.000216	CcSEcCtD
Fluticasone Propionate—Urticaria—Capecitabine—breast cancer	2.02e-05	0.000216	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Epirubicin—breast cancer	2.02e-05	0.000215	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Capecitabine—breast cancer	2.01e-05	0.000215	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Capecitabine—breast cancer	2.01e-05	0.000215	CcSEcCtD
Fluticasone Propionate—Erythema—Doxorubicin—breast cancer	2.01e-05	0.000215	CcSEcCtD
Fluticasone Propionate—Malnutrition—Doxorubicin—breast cancer	2.01e-05	0.000215	CcSEcCtD
Fluticasone Propionate—Agitation—Epirubicin—breast cancer	2e-05	0.000213	CcSEcCtD
Fluticasone Propionate—Arthralgia—Methotrexate—breast cancer	1.98e-05	0.000211	CcSEcCtD
Fluticasone Propionate—Chest pain—Methotrexate—breast cancer	1.98e-05	0.000211	CcSEcCtD
Fluticasone Propionate—Vomiting—Paclitaxel—breast cancer	1.97e-05	0.00021	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	1.96e-05	0.000209	CcSEcCtD
Fluticasone Propionate—Malaise—Epirubicin—breast cancer	1.96e-05	0.000209	CcSEcCtD
Fluticasone Propionate—Rash—Paclitaxel—breast cancer	1.96e-05	0.000209	CcSEcCtD
Fluticasone Propionate—Dermatitis—Paclitaxel—breast cancer	1.95e-05	0.000208	CcSEcCtD
Fluticasone Propionate—Discomfort—Methotrexate—breast cancer	1.95e-05	0.000208	CcSEcCtD
Fluticasone Propionate—Headache—Paclitaxel—breast cancer	1.94e-05	0.000207	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Docetaxel—breast cancer	1.94e-05	0.000207	CcSEcCtD
Fluticasone Propionate—Muscle spasms—Doxorubicin—breast cancer	1.93e-05	0.000206	CcSEcCtD
Fluticasone Propionate—Palpitations—Epirubicin—breast cancer	1.92e-05	0.000205	CcSEcCtD
Fluticasone Propionate—Cough—Epirubicin—breast cancer	1.9e-05	0.000202	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Methotrexate—breast cancer	1.9e-05	0.000202	CcSEcCtD
Fluticasone Propionate—Vision blurred—Doxorubicin—breast cancer	1.9e-05	0.000202	CcSEcCtD
Fluticasone Propionate—Infection—Methotrexate—breast cancer	1.88e-05	0.000201	CcSEcCtD
Fluticasone Propionate—Hypertension—Epirubicin—breast cancer	1.88e-05	0.0002	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Capecitabine—breast cancer	1.88e-05	0.0002	CcSEcCtD
Fluticasone Propionate—Dexamethasone—CYP3A4—breast cancer	1.87e-05	0.0119	CrCbGaD
Fluticasone Propionate—Ill-defined disorder—Doxorubicin—breast cancer	1.87e-05	0.000199	CcSEcCtD
Fluticasone Propionate—Pruritus—Docetaxel—breast cancer	1.86e-05	0.000198	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Methotrexate—breast cancer	1.86e-05	0.000198	CcSEcCtD
Fluticasone Propionate—Arthralgia—Epirubicin—breast cancer	1.85e-05	0.000197	CcSEcCtD
Fluticasone Propionate—Chest pain—Epirubicin—breast cancer	1.85e-05	0.000197	CcSEcCtD
Fluticasone Propionate—Agitation—Doxorubicin—breast cancer	1.85e-05	0.000197	CcSEcCtD
Fluticasone Propionate—Anxiety—Epirubicin—breast cancer	1.84e-05	0.000197	CcSEcCtD
Fluticasone Propionate—Nausea—Paclitaxel—breast cancer	1.84e-05	0.000197	CcSEcCtD
Fluticasone Propionate—Skin disorder—Methotrexate—breast cancer	1.84e-05	0.000196	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	1.84e-05	0.000196	CcSEcCtD
Fluticasone Propionate—Dexamethasone—PTGS2—breast cancer	1.83e-05	0.0117	CrCbGaD
Fluticasone Propionate—Discomfort—Epirubicin—breast cancer	1.83e-05	0.000195	CcSEcCtD
Fluticasone Propionate—Malaise—Doxorubicin—breast cancer	1.81e-05	0.000193	CcSEcCtD
Fluticasone Propionate—Dry mouth—Epirubicin—breast cancer	1.81e-05	0.000193	CcSEcCtD
Fluticasone Propionate—Pruritus—Capecitabine—breast cancer	1.8e-05	0.000192	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Docetaxel—breast cancer	1.8e-05	0.000192	CcSEcCtD
Fluticasone Propionate—Palpitations—Doxorubicin—breast cancer	1.78e-05	0.00019	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Epirubicin—breast cancer	1.77e-05	0.000189	CcSEcCtD
Fluticasone Propionate—Oedema—Epirubicin—breast cancer	1.77e-05	0.000189	CcSEcCtD
Fluticasone Propionate—Infection—Epirubicin—breast cancer	1.76e-05	0.000188	CcSEcCtD
Fluticasone Propionate—Cough—Doxorubicin—breast cancer	1.76e-05	0.000187	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Capecitabine—breast cancer	1.74e-05	0.000186	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Epirubicin—breast cancer	1.74e-05	0.000186	CcSEcCtD
Fluticasone Propionate—Dizziness—Docetaxel—breast cancer	1.74e-05	0.000185	CcSEcCtD
Fluticasone Propionate—Hypertension—Doxorubicin—breast cancer	1.74e-05	0.000185	CcSEcCtD
Fluticasone Propionate—Tachycardia—Epirubicin—breast cancer	1.73e-05	0.000185	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Methotrexate—breast cancer	1.73e-05	0.000184	CcSEcCtD
Fluticasone Propionate—Skin disorder—Epirubicin—breast cancer	1.72e-05	0.000184	CcSEcCtD
Fluticasone Propionate—Chest pain—Doxorubicin—breast cancer	1.71e-05	0.000183	CcSEcCtD
Fluticasone Propionate—Arthralgia—Doxorubicin—breast cancer	1.71e-05	0.000183	CcSEcCtD
Fluticasone Propionate—Anxiety—Doxorubicin—breast cancer	1.71e-05	0.000182	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	1.7e-05	0.000181	CcSEcCtD
Fluticasone Propionate—Discomfort—Doxorubicin—breast cancer	1.69e-05	0.00018	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Methotrexate—breast cancer	1.69e-05	0.00018	CcSEcCtD
Fluticasone Propionate—Dizziness—Capecitabine—breast cancer	1.68e-05	0.00018	CcSEcCtD
Fluticasone Propionate—Dry mouth—Doxorubicin—breast cancer	1.67e-05	0.000179	CcSEcCtD
Fluticasone Propionate—Vomiting—Docetaxel—breast cancer	1.67e-05	0.000178	CcSEcCtD
Fluticasone Propionate—Rash—Docetaxel—breast cancer	1.66e-05	0.000177	CcSEcCtD
Fluticasone Propionate—Dermatitis—Docetaxel—breast cancer	1.66e-05	0.000177	CcSEcCtD
Fluticasone Propionate—Headache—Docetaxel—breast cancer	1.65e-05	0.000176	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Doxorubicin—breast cancer	1.64e-05	0.000175	CcSEcCtD
Fluticasone Propionate—Oedema—Doxorubicin—breast cancer	1.64e-05	0.000175	CcSEcCtD
Fluticasone Propionate—Infection—Doxorubicin—breast cancer	1.63e-05	0.000174	CcSEcCtD
Fluticasone Propionate—Pain—Methotrexate—breast cancer	1.62e-05	0.000173	CcSEcCtD
Fluticasone Propionate—Vomiting—Capecitabine—breast cancer	1.62e-05	0.000173	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Epirubicin—breast cancer	1.62e-05	0.000172	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Doxorubicin—breast cancer	1.61e-05	0.000172	CcSEcCtD
Fluticasone Propionate—Rash—Capecitabine—breast cancer	1.61e-05	0.000171	CcSEcCtD
Fluticasone Propionate—Dermatitis—Capecitabine—breast cancer	1.6e-05	0.000171	CcSEcCtD
Fluticasone Propionate—Tachycardia—Doxorubicin—breast cancer	1.6e-05	0.000171	CcSEcCtD
Fluticasone Propionate—Headache—Capecitabine—breast cancer	1.6e-05	0.00017	CcSEcCtD
Fluticasone Propionate—Skin disorder—Doxorubicin—breast cancer	1.59e-05	0.00017	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Epirubicin—breast cancer	1.58e-05	0.000169	CcSEcCtD
Fluticasone Propionate—Nausea—Docetaxel—breast cancer	1.56e-05	0.000167	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Methotrexate—breast cancer	1.56e-05	0.000167	CcSEcCtD
Fluticasone Propionate—Dexamethasone—ABCB1—breast cancer	1.56e-05	0.00995	CrCbGaD
Fluticasone Propionate—Gastrointestinal pain—Methotrexate—breast cancer	1.55e-05	0.000165	CcSEcCtD
Fluticasone Propionate—Pain—Epirubicin—breast cancer	1.52e-05	0.000162	CcSEcCtD
Fluticasone Propionate—Nausea—Capecitabine—breast cancer	1.51e-05	0.000161	CcSEcCtD
Fluticasone Propionate—Urticaria—Methotrexate—breast cancer	1.51e-05	0.000161	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Methotrexate—breast cancer	1.5e-05	0.00016	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Methotrexate—breast cancer	1.5e-05	0.00016	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Doxorubicin—breast cancer	1.5e-05	0.000159	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Doxorubicin—breast cancer	1.46e-05	0.000156	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Epirubicin—breast cancer	1.46e-05	0.000156	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Epirubicin—breast cancer	1.45e-05	0.000155	CcSEcCtD
Fluticasone Propionate—Urticaria—Epirubicin—breast cancer	1.41e-05	0.00015	CcSEcCtD
Fluticasone Propionate—Pain—Doxorubicin—breast cancer	1.4e-05	0.00015	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Epirubicin—breast cancer	1.4e-05	0.00015	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Epirubicin—breast cancer	1.4e-05	0.00015	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Methotrexate—breast cancer	1.4e-05	0.000149	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Doxorubicin—breast cancer	1.35e-05	0.000144	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Doxorubicin—breast cancer	1.34e-05	0.000143	CcSEcCtD
Fluticasone Propionate—Pruritus—Methotrexate—breast cancer	1.34e-05	0.000143	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Epirubicin—breast cancer	1.31e-05	0.000139	CcSEcCtD
Fluticasone Propionate—Urticaria—Doxorubicin—breast cancer	1.3e-05	0.000139	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Doxorubicin—breast cancer	1.3e-05	0.000138	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Doxorubicin—breast cancer	1.3e-05	0.000138	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Methotrexate—breast cancer	1.3e-05	0.000138	CcSEcCtD
Fluticasone Propionate—Pruritus—Epirubicin—breast cancer	1.26e-05	0.000134	CcSEcCtD
Fluticasone Propionate—Dizziness—Methotrexate—breast cancer	1.25e-05	0.000134	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Epirubicin—breast cancer	1.21e-05	0.000129	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Doxorubicin—breast cancer	1.21e-05	0.000129	CcSEcCtD
Fluticasone Propionate—Vomiting—Methotrexate—breast cancer	1.21e-05	0.000129	CcSEcCtD
Fluticasone Propionate—Rash—Methotrexate—breast cancer	1.2e-05	0.000127	CcSEcCtD
Fluticasone Propionate—Dermatitis—Methotrexate—breast cancer	1.19e-05	0.000127	CcSEcCtD
Fluticasone Propionate—Headache—Methotrexate—breast cancer	1.19e-05	0.000127	CcSEcCtD
Fluticasone Propionate—Dizziness—Epirubicin—breast cancer	1.17e-05	0.000125	CcSEcCtD
Fluticasone Propionate—Pruritus—Doxorubicin—breast cancer	1.16e-05	0.000124	CcSEcCtD
Fluticasone Propionate—Vomiting—Epirubicin—breast cancer	1.13e-05	0.00012	CcSEcCtD
Fluticasone Propionate—Nausea—Methotrexate—breast cancer	1.13e-05	0.00012	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Doxorubicin—breast cancer	1.12e-05	0.00012	CcSEcCtD
Fluticasone Propionate—Rash—Epirubicin—breast cancer	1.12e-05	0.000119	CcSEcCtD
Fluticasone Propionate—Dermatitis—Epirubicin—breast cancer	1.12e-05	0.000119	CcSEcCtD
Fluticasone Propionate—Headache—Epirubicin—breast cancer	1.11e-05	0.000119	CcSEcCtD
Fluticasone Propionate—Dizziness—Doxorubicin—breast cancer	1.09e-05	0.000116	CcSEcCtD
Fluticasone Propionate—Nausea—Epirubicin—breast cancer	1.05e-05	0.000112	CcSEcCtD
Fluticasone Propionate—Vomiting—Doxorubicin—breast cancer	1.04e-05	0.000111	CcSEcCtD
Fluticasone Propionate—Rash—Doxorubicin—breast cancer	1.04e-05	0.00011	CcSEcCtD
Fluticasone Propionate—Dermatitis—Doxorubicin—breast cancer	1.03e-05	0.00011	CcSEcCtD
Fluticasone Propionate—Headache—Doxorubicin—breast cancer	1.03e-05	0.00011	CcSEcCtD
Fluticasone Propionate—Nausea—Doxorubicin—breast cancer	9.75e-06	0.000104	CcSEcCtD
Fluticasone Propionate—CYP3A7—Metabolism—ITPR1—breast cancer	3.12e-06	5.29e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PIK3CG—breast cancer	3.11e-06	5.26e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ENO1—breast cancer	3.1e-06	5.25e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PTGS1—breast cancer	3.1e-06	5.25e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—IL2—breast cancer	3.09e-06	5.24e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—TERT—breast cancer	3.08e-06	5.22e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—APRT—breast cancer	3.08e-06	5.22e-05	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—AKT1—breast cancer	3.06e-06	5.19e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CYP2D6—breast cancer	3.04e-06	5.15e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—ABCB1—breast cancer	3e-06	5.09e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—FGFR1—breast cancer	2.99e-06	5.07e-05	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—ESR1—breast cancer	2.99e-06	5.07e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—BRAF—breast cancer	2.99e-06	5.06e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—NCOA2—breast cancer	2.98e-06	5.06e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—TYMS—breast cancer	2.95e-06	5e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—HIF1A—breast cancer	2.95e-06	5e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—AKT1—breast cancer	2.92e-06	4.95e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—GSTM1—breast cancer	2.91e-06	4.94e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PLA2G4A—breast cancer	2.91e-06	4.94e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—NCOR1—breast cancer	2.91e-06	4.94e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—IGF1—breast cancer	2.91e-06	4.93e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—AKT2—breast cancer	2.91e-06	4.93e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ESRRA—breast cancer	2.89e-06	4.9e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ANGPTL4—breast cancer	2.89e-06	4.9e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—FASN—breast cancer	2.89e-06	4.9e-05	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—NOTCH1—breast cancer	2.89e-06	4.9e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—BCHE—breast cancer	2.88e-06	4.88e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—LEP—breast cancer	2.88e-06	4.88e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CAV1—breast cancer	2.85e-06	4.83e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—SLC5A5—breast cancer	2.85e-06	4.82e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—KDR—breast cancer	2.82e-06	4.78e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PIK3CD—breast cancer	2.79e-06	4.74e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—GPX1—breast cancer	2.79e-06	4.73e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—MAPK3—breast cancer	2.77e-06	4.69e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—SERPINE1—breast cancer	2.76e-06	4.68e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CYP1A1—breast cancer	2.76e-06	4.68e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—SLC2A1—breast cancer	2.75e-06	4.66e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—NQO1—breast cancer	2.75e-06	4.66e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—ESR1—breast cancer	2.75e-06	4.66e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GPI—breast cancer	2.74e-06	4.65e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—HADHB—breast cancer	2.74e-06	4.65e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—ERCC2—breast cancer	2.74e-06	4.64e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PIK3CD—breast cancer	2.73e-06	4.63e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—FN1—breast cancer	2.71e-06	4.6e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—ALB—breast cancer	2.69e-06	4.57e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—MYC—breast cancer	2.69e-06	4.56e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—NFKBIA—breast cancer	2.68e-06	4.54e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CYP3A4—breast cancer	2.68e-06	4.54e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—NOTCH1—breast cancer	2.66e-06	4.5e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—NOS3—breast cancer	2.64e-06	4.47e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CYP1B1—breast cancer	2.63e-06	4.47e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ALDH1A1—breast cancer	2.62e-06	4.44e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ALDH7A1—breast cancer	2.62e-06	4.44e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—KIT—breast cancer	2.6e-06	4.4e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—APC—breast cancer	2.6e-06	4.4e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PIK3CG—breast cancer	2.6e-06	4.4e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—HSP90AA1—breast cancer	2.58e-06	4.38e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—NOS3—breast cancer	2.58e-06	4.37e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—MTHFR—breast cancer	2.58e-06	4.37e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—EGF—breast cancer	2.57e-06	4.35e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—NCOA1—breast cancer	2.51e-06	4.26e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—NME1—breast cancer	2.51e-06	4.25e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ADSL—breast cancer	2.51e-06	4.25e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—FHL2—breast cancer	2.51e-06	4.25e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—UMPS—breast cancer	2.51e-06	4.25e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PHGDH—breast cancer	2.51e-06	4.25e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MDM2—breast cancer	2.5e-06	4.24e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—RAF1—breast cancer	2.49e-06	4.23e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—MAPK3—breast cancer	2.49e-06	4.22e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—RELA—breast cancer	2.48e-06	4.21e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CYP19A1—breast cancer	2.48e-06	4.2e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—STK11—breast cancer	2.48e-06	4.2e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—ERBB2—breast cancer	2.47e-06	4.18e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—HPSE—breast cancer	2.46e-06	4.17e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—BRIP1—breast cancer	2.46e-06	4.17e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—LDHB—breast cancer	2.46e-06	4.17e-05	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—SERPINE1—breast cancer	2.46e-06	4.16e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—BRAF—breast cancer	2.44e-06	4.14e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MTOR—breast cancer	2.44e-06	4.13e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PIK3CB—breast cancer	2.44e-06	4.13e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PIK3CB—breast cancer	2.38e-06	4.03e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—IGF1—breast cancer	2.38e-06	4.03e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CAV1—breast cancer	2.38e-06	4.03e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—AKT2—breast cancer	2.38e-06	4.03e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—EGFR—breast cancer	2.37e-06	4.01e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PTGS2—breast cancer	2.36e-06	4e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CXCL8—breast cancer	2.34e-06	3.97e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GSTA3—breast cancer	2.33e-06	3.95e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—HMMR—breast cancer	2.33e-06	3.95e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ABCC1—breast cancer	2.33e-06	3.95e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—COMT—breast cancer	2.3e-06	3.9e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—GSTP1—breast cancer	2.29e-06	3.89e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CDKN1B—breast cancer	2.29e-06	3.87e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PIK3CD—breast cancer	2.28e-06	3.87e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—HMOX1—breast cancer	2.26e-06	3.83e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PPARGC1B—breast cancer	2.26e-06	3.83e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—SERPINE1—breast cancer	2.26e-06	3.83e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ITPR1—breast cancer	2.26e-06	3.82e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CASP3—breast cancer	2.24e-06	3.8e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—IL2—breast cancer	2.24e-06	3.79e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—KRAS—breast cancer	2.23e-06	3.79e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CCND1—breast cancer	2.18e-06	3.7e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—JUN—breast cancer	2.18e-06	3.69e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ABCB1—breast cancer	2.17e-06	3.68e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PIK3CG—breast cancer	2.16e-06	3.67e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CTNNB1—breast cancer	2.16e-06	3.66e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—NOS3—breast cancer	2.16e-06	3.65e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GSTA4—breast cancer	2.13e-06	3.62e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CA9—breast cancer	2.13e-06	3.62e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—TYMS—breast cancer	2.13e-06	3.61e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MMP9—breast cancer	2.12e-06	3.59e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CDKN1A—breast cancer	2.11e-06	3.58e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—GSTM1—breast cancer	2.11e-06	3.57e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PLA2G4A—breast cancer	2.11e-06	3.57e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—NCOR1—breast cancer	2.11e-06	3.57e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PTEN—breast cancer	2.1e-06	3.57e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GPX2—breast cancer	2.08e-06	3.52e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GSTA2—breast cancer	2.08e-06	3.52e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MAPK8—breast cancer	2.06e-06	3.49e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PTEN—breast cancer	2.06e-06	3.49e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—SULT1A1—breast cancer	2.05e-06	3.48e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GPX4—breast cancer	2.05e-06	3.48e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—PIK3CA—breast cancer	2.05e-06	3.48e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MDM2—breast cancer	2.04e-06	3.47e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—RAF1—breast cancer	2.04e-06	3.45e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—RELA—breast cancer	2.03e-06	3.44e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—GPX1—breast cancer	2.02e-06	3.42e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—ERBB2—breast cancer	2.02e-06	3.42e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GSTA1—breast cancer	2.01e-06	3.4e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—IDH1—breast cancer	2.01e-06	3.4e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CYP1A1—breast cancer	2e-06	3.39e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MTOR—breast cancer	1.99e-06	3.37e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PIK3CB—breast cancer	1.99e-06	3.37e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—NAT2—breast cancer	1.98e-06	3.36e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ERCC2—breast cancer	1.98e-06	3.36e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—SRC—breast cancer	1.95e-06	3.31e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CXCL8—breast cancer	1.91e-06	3.24e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PIK3CD—breast cancer	1.9e-06	3.22e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—VEGFA—breast cancer	1.9e-06	3.22e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—HRAS—breast cancer	1.9e-06	3.22e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—STAT3—breast cancer	1.88e-06	3.19e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—ALB—breast cancer	1.88e-06	3.18e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CDKN1B—breast cancer	1.87e-06	3.16e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—AKT1—breast cancer	1.87e-06	3.16e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—MTHFR—breast cancer	1.86e-06	3.16e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CASP3—breast cancer	1.83e-06	3.1e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—IL2—breast cancer	1.83e-06	3.1e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—IL6—breast cancer	1.82e-06	3.08e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MAPK3—breast cancer	1.8e-06	3.05e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—NOS3—breast cancer	1.8e-06	3.04e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CCND1—breast cancer	1.78e-06	3.02e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—JUN—breast cancer	1.78e-06	3.01e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CTNNB1—breast cancer	1.76e-06	2.99e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MYC—breast cancer	1.75e-06	2.96e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—TGFB1—breast cancer	1.74e-06	2.96e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—MED12—breast cancer	1.74e-06	2.95e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—DPYD—breast cancer	1.74e-06	2.95e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MMP9—breast cancer	1.73e-06	2.93e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CDKN1A—breast cancer	1.72e-06	2.92e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PTEN—breast cancer	1.72e-06	2.91e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CAV1—breast cancer	1.72e-06	2.91e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ALDOA—breast cancer	1.71e-06	2.9e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—EGFR—breast cancer	1.71e-06	2.9e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MAPK8—breast cancer	1.68e-06	2.85e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—AKT1—breast cancer	1.68e-06	2.84e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—NCOA3—breast cancer	1.66e-06	2.82e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PIK3CB—breast cancer	1.66e-06	2.81e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—SLC2A2—breast cancer	1.65e-06	2.8e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PTGS2—breast cancer	1.64e-06	2.78e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CPT1A—breast cancer	1.62e-06	2.74e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ABCG2—breast cancer	1.62e-06	2.74e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—MTR—breast cancer	1.62e-06	2.74e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—KRAS—breast cancer	1.62e-06	2.74e-05	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—MAPK3—breast cancer	1.6e-06	2.71e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—SRC—breast cancer	1.59e-06	2.7e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—HPGDS—breast cancer	1.59e-06	2.69e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—HBA1—breast cancer	1.58e-06	2.67e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PIK3CG—breast cancer	1.56e-06	2.65e-05	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—MYC—breast cancer	1.55e-06	2.64e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—VEGFA—breast cancer	1.55e-06	2.63e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ACHE—breast cancer	1.54e-06	2.61e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GSTT1—breast cancer	1.54e-06	2.61e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—STAT3—breast cancer	1.54e-06	2.61e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PIK3CA—breast cancer	1.48e-06	2.52e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MAPK3—breast cancer	1.47e-06	2.49e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CYP17A1—breast cancer	1.46e-06	2.47e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PIK3CA—breast cancer	1.45e-06	2.46e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ENO1—breast cancer	1.44e-06	2.44e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PTGS1—breast cancer	1.44e-06	2.44e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—TP53—breast cancer	1.44e-06	2.43e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PTEN—breast cancer	1.43e-06	2.43e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MYC—breast cancer	1.43e-06	2.42e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—TGFB1—breast cancer	1.43e-06	2.42e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CYP2D6—breast cancer	1.41e-06	2.4e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—EGFR—breast cancer	1.4e-06	2.37e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—NCOA2—breast cancer	1.39e-06	2.35e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PIK3CD—breast cancer	1.38e-06	2.33e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—HRAS—breast cancer	1.37e-06	2.33e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ALB—breast cancer	1.36e-06	2.3e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—FASN—breast cancer	1.35e-06	2.28e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—BCHE—breast cancer	1.34e-06	2.27e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—SLC5A5—breast cancer	1.32e-06	2.24e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—KRAS—breast cancer	1.32e-06	2.24e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—IL6—breast cancer	1.31e-06	2.23e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—NOS3—breast cancer	1.3e-06	2.2e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—NQO1—breast cancer	1.28e-06	2.17e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—SLC2A1—breast cancer	1.28e-06	2.17e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CYP1B1—breast cancer	1.23e-06	2.08e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—AKT1—breast cancer	1.21e-06	2.06e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PIK3CA—breast cancer	1.21e-06	2.06e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—HSP90AA1—breast cancer	1.2e-06	2.04e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PIK3CB—breast cancer	1.2e-06	2.03e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PTGS2—breast cancer	1.19e-06	2.01e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—AKT1—breast cancer	1.18e-06	2.01e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—TP53—breast cancer	1.17e-06	1.99e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—NCOA1—breast cancer	1.17e-06	1.98e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—STK11—breast cancer	1.15e-06	1.95e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CYP19A1—breast cancer	1.15e-06	1.95e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—HRAS—breast cancer	1.12e-06	1.9e-05	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—AKT1—breast cancer	1.08e-06	1.83e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—IL6—breast cancer	1.07e-06	1.82e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—COMT—breast cancer	1.07e-06	1.82e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GSTP1—breast cancer	1.07e-06	1.81e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—HMOX1—breast cancer	1.05e-06	1.78e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ITPR1—breast cancer	1.05e-06	1.78e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PTEN—breast cancer	1.04e-06	1.76e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PIK3CA—breast cancer	1.01e-06	1.71e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ABCB1—breast cancer	1.01e-06	1.71e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—TYMS—breast cancer	9.91e-07	1.68e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—AKT1—breast cancer	9.91e-07	1.68e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GSTM1—breast cancer	9.79e-07	1.66e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—NCOR1—breast cancer	9.79e-07	1.66e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PLA2G4A—breast cancer	9.79e-07	1.66e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GPX1—breast cancer	9.38e-07	1.59e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CYP1A1—breast cancer	9.28e-07	1.57e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ERCC2—breast cancer	9.21e-07	1.56e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—MTHFR—breast cancer	8.66e-07	1.47e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—AKT1—breast cancer	8.26e-07	1.4e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CAV1—breast cancer	7.98e-07	1.35e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PIK3CA—breast cancer	7.31e-07	1.24e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PIK3CG—breast cancer	7.27e-07	1.23e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PIK3CD—breast cancer	6.39e-07	1.08e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ALB—breast cancer	6.31e-07	1.07e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—NOS3—breast cancer	6.04e-07	1.02e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—AKT1—breast cancer	5.97e-07	1.01e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PIK3CB—breast cancer	5.57e-07	9.45e-06	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PTGS2—breast cancer	5.52e-07	9.36e-06	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PTEN—breast cancer	4.81e-07	8.16e-06	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PIK3CA—breast cancer	3.4e-07	5.76e-06	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—AKT1—breast cancer	2.77e-07	4.7e-06	CbGpPWpGaD
